• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Cordarone (amiodarone HCl) 200 mg tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- September 2009

 

Summary View

 

WARNINGS

Pulmonary Toxicity
  • pleural effusion
  • (including eosinophilic pneumonia)” has been added to the pneumonitis listing

ADVERSE REACTIONS

  • There have been spontaneous reports of demyelinating polyneuropathy
Postmarketing Reports
  • Eosinophilic pneumonia, pleural effusion, and demyelinating polyneuropathy

MEDICATION GUIDE

  • Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.